🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This study will determine the maximum tolerated dose (MTD) of arbaclofen pl...
Status
Completed
Location
Research Centers of America
Start Date
2015-09
Trial ID
NCT02511886
Treatments Being Tested
Study 22001, "A Double-Blind, Placebo-Controlled, Flexible-Dose Evaluation ...
Status
Terminated
Location
University of California-Los Angeles Neuropsychiatric Institute
Start Date
2009-11
Trial ID
NCT01013480
Treatments Being Tested
To explore the efficacy, safety and tolerability of STX209 (arbaclofen) adm...
Status
Completed
Location
Southwest Autism Research & Resource Center
Start Date
2011-05
Trial ID
NCT01282268
Treatments Being Tested
This study will enroll subjects who have completed Protocols 209FX301, 209F...
Status
Terminated
Location
Seaside Therapeutics Site #16
Start Date
2011-11
Trial ID
NCT01555333
Treatments Being Tested
The purpose of the study is to evaluate safety and tolerability of arbaclof...
Status
Completed
Location
Multiple Locations
Start Date
2008-12
Trial ID
NCT00817986
Treatments Being Tested
This is a multicenter, randomized (1:1:1), double-blind, active and placebo...
Status
Completed
Location
Osmotica Study Site-138
Start Date
2012-11
Trial ID
NCT01743651
Treatments Being Tested
AIMS-2-CT-01 is a randomized, double-blind, placebo controlled, study to ex...
Status
Completed
Location
Robert Debré Hospital
Start Date
2019-09-19
Trial ID
NCT03682978
Treatments Being Tested
To evaluate the efficacy of three doses of XP19986 (arbaclofen placarbil) c...
Status
Completed
Location
XenoPort Clinical Site
Start Date
2011-05
Trial ID
NCT01359566
Clinical protocol OS440-3003 is a multicenter, open-label, non-randomized, ...
Status
Completed
Location
Osmotica Study Site-154
Start Date
2013-04
Trial ID
NCT01844232
Treatments Being Tested
Spasticity is a common complication in MS and occurs in up to 84% of patien...
Status
Completed
Location
Neuro Pain Medical Center
Start Date
2018-04-03
Trial ID
NCT03319732
Treatments Being Tested